(Q39823165)

English

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates (English)

1 reference

Europe PubMed Central

14 September 2017

0 references

1 reference

based on heuristic

inferred from title

Arturo Reyes-Sandoval

object named as

Arturo Reyes-Sandoval

2

0 references

Stefania Capone

object named as

Stefania Capone

1

0 references

Adrian V. S. Hill

11

object named as

Adrian V S Hill

1 reference

Europe PubMed Central

14 September 2017

author name string

Mariarosaria Naddeo

3

1 reference

Europe PubMed Central

14 September 2017

Loredana Siani

4

1 reference

Europe PubMed Central

14 September 2017

Virginia Ammendola

5

1 reference

Europe PubMed Central

14 September 2017

Christine S Rollier

6

1 reference

Europe PubMed Central

14 September 2017

Alfredo Nicosia

7

1 reference

Europe PubMed Central

14 September 2017

Stefano Colloca

8

1 reference

Europe PubMed Central

14 September 2017

Riccardo Cortese

9

1 reference

Europe PubMed Central

14 September 2017

Antonella Folgori

10

1 reference

Europe PubMed Central

14 September 2017

language of work or name

0 references

publication date

26 October 2010

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

29

1 reference

Europe PubMed Central

14 September 2017

2

1 reference

Europe PubMed Central

14 September 2017

256-265

1 reference

Europe PubMed Central

14 September 2017

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Chimpanzee adenovirus vaccine protects against Zaire Ebola virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Chimpanzee-origin adenovirus vectors as vaccine carriers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Modulation of the immune response induced by gene electrotransfer of a hepatitis C virus DNA vaccine in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Induction of mucosal immunity with a replication-defective adenoviral recombinant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Dominant CD8+ T-lymphocyte responses suppress expansion of vaccine-elicited subdominant T lymphocytes in rhesus monkeys challenged with pathogenic simian-human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Immunological techniques in viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

CD4+CD8+ murine intestinal intraepithelial lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Extrathymic CD4/CD8 double positive T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Prime-boost vectored malaria vaccines: progress and prospects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Adenovirus-mediated gene transfer to liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

A theoretical framework for the immunoepidemiology of Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

Simian immunodeficiency virus infection of CD8+ lymphocytes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.041

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2010.10.041

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39823165&oldid=2090947803"